期刊文献+

瑞舒伐他汀对颈动脉斑块的影响 被引量:2

下载PDF
导出
摘要 近年来,随着生活节奏的加快,生活方式和饮食习惯的改变,冠心病的发病率在逐年升高,成为威胁人类健康的重要原因,其发病基础为动脉粥样硬化。高胆固醇血症是动脉粥样硬化和冠心病的最重要危险因素,对高胆固醇血症有效的预防和治疗对于预防动脉粥样硬化和冠心病有重要的意义。近年来,大量研究表明评价动脉粥样硬化的重要指标是颈动脉内膜-中层厚度(intima-mediu thickness ,IM T )和血管内皮依赖性舒张功能(EDFMD )。针对高胆固醇血症患者抗动脉粥样硬化和改善血管内皮功能治疗,对防治动脉粥样硬化和冠心病有重要的意义。
作者 龚建祖
出处 《滨州医学院学报》 2014年第2期149-150,共2页 Journal of Binzhou Medical University
  • 相关文献

参考文献17

  • 1赵水平.他汀类药物防治冠心病的临床应用[J].中华心血管病杂志,2003,31(4):316-318. 被引量:29
  • 2Sillesen H. Statins and their use in preventing carotid disease [J]. Curr Atheroscler Rep,2009,11(4) : 309-314.
  • 3Ray KK, Cannon CP, Cairns R, et al. Prognostic utility of apoB/ AI, total cholesterol /HDL, non-HDL cholesterol, or hs-CRP as predictors of clinical risk in patients receiving statin therapy after acute coronary syndromes: results from PROVE IT TIMI 22 [J]. Arterioscler Thromh Vasc Bio1,2009,29(3):424-430.
  • 4Ballantyne CM, Raiehlen JS, Nicholis SJ, et al. Effect of rosuvas- tatin therapy on coronary artery stenoses assessed by quantita- tive coronary angiography: a study to evaluate the effect of rosu- vastatin on intravascular ultrasound- derived coronary athero ma burden[J]. Circulation, 2008,117 (19) : 2458-2466.
  • 5Ridker PM, Danielson E, Fonseca FA, et al. Rosuvastatlon to prevent vascular events in men and women with elevated C-reac- tive protein[J]. N Engl J Med,2008,359(21) :2195- 2207.
  • 6Everett BM, Glynn RJ, MacFadyen JG,et al. Rosuvastatin in the prevention of stroke among men and women with elevated levels of C-reactive protein: iustification for the Use of Statins in Pre- vention: an Intervention Trial Evaluating Rosuvastatin(JUPl- TER )[J]. Circulation, 2010, 121 ( 1 ) : 143-150.
  • 7Mora S,Glynn R J, Hsia J,et al. Statins for the primary preven- tion of cardiovascular events in women with elevated high-sensi tivity C reactive protein or dyslipidemia:results from the Justifi- cation for the Use of Statins in Prevention: An Intervention Trial Evaluating Rosuvastatin ( JUPITER ) and meta-analysis of women from primary prevention trials[J]. Circulation, 2010,121 (9) : 1069-1077.
  • 8Peters SA,Palmer MK, Grobbee DE, et al. C-reactive protein lowering with rosuvastatin in the METEOR study[J]. J Intern Med,2010,268(2) : 155-161.
  • 9Haddad RM, Ballantyne CM. METEOR Trial reports on the effect of rosuvastatin on progression of carotid intima media thickness in low risk individuals with subclinical atherosclerosis [J]. Phys Sportsmed, 2010,38(2) : 180-182.
  • 10夏普,林从全,徐静,胡淑兰,张明妍.不同剂量瑞舒伐他汀治疗颈动脉斑块形成合并高脂血症的临床疗效对比析[J].中国医药指南,2012,10(27):38-39. 被引量:6

二级参考文献41

共引文献158

同被引文献16

引证文献2

二级引证文献7

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部